The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Notice for teduglutide (Shire Australia Pty Limited)
Active ingredients
teduglutide
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Injection solution
Indication
For the treatment of paediatric patients with Short Bowel Syndrome (SBS)
Therapeutic area
Gastroenterology